Diagnostic and Prognostic Biomarker Database Launched

Share |

A database of 29,000 unique biomarkers (for more than 1800 human diseases), which are manually extracted from US patent/WO (PCT) publications and PubMed abstracts.

Madison, WI (I-Newswire) March 8, 2011 - In this new era of personalized medicine, there is a growing trend for custom synthesis of drugs for each and every patient depending on his/her genetic profile and biomarker discovery has come to the forefront of drug discovery research. The rapid growth of biomarker discovery has expanded to the point at which the application of technically advanced biomarkers will provide a dynamic and powerful approach to understanding the spectrum of various disease with applications in analytic epidemiology, clinical trials and disease prevention, diagnosis, and disease management. Biomarkers will be used as tools for target discovery, noninvasive early stage diagnosis of diseases, for evaluation of mode of action of a drug, dose determination and prediction of the drug effect. It will accelerate not only development of non-toxic and effective drugs but also help in monitoring patient health and response towards drug treatments.

Sciclips has been a pioneer in developing databases in the field of drug targets. With the growing trend of personalized healthcare concept and advancement in biomarker research, there is a need for a biomarker database. Sciclips has launched a unique biomarker database that has listed more than 29,000 biomarkers. Biomarkers in this database have been manually extracted from US patent and WO (PCT) publications and PubMed abstracts The database contains biomarkers of diverse nature such as Protein/peptide/antibody biomarkers (7279 unique biomarkers); molecular diagnostic biomarkers (7206 unique biomarkers), which contain nucleic acid-bases biomarkers DNA, SNPs and mRNA expression profile, including linkage disequilibrium biomarkers ; Drug efficacy/response biomarkers (7708 unique biomarkers), which are for monitoring the efficacy of the therapy, response of a biomarker for a drug treatment or determining the severity or monitoring the progression of a disease; Disease risk assessment and predictive biomarkers (10,375 unique biomarkers) for predicting risk of developing certain diseases as well as prognostic biomarkers. Other biomarkers include epigenetic biomarkers (700 unique biomarker), which are based mainly on DNA methylation changes, histone modifications; metabolomic biomarkers (811 unique biomarkers), MicroRNA (miRNA) biomarkers (935 unique biomarkers); Cell-based biomarkers (27 unique biomarkers); and genotoxic/carcinogenic biomarkers (47 unique biomarkers).This database will provide all the information needed for biomarker research and will help to open-up innovations in personalized medicine. Please visit our drug target section to access the database.

About Sciclips LLC:
SciClips is a Web-based company that facilitates scientific collaboration and open innovation among scientists and researchers from around the world.

Company Contact Information
Sciclips LLC
Sanchayita Kar
1202 Ann Street , Madison, WI
53713
Phone : 608-6610375

Print Release

Share this News Release

Published in:

Medical > Research

Tags:

biomarkers Clinical diagnostics Molecular diagnostics

Published on:

March 8, 2011

Content Disclaimer: If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service company and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter,make sure to check the official company website for accurate release dates as our site displays the date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.

Related Releases

Odessa’s Healthy Heart Center Celebrates Ten Years of Helping Heart Patients Live Active, Symptom-Free Lives with the Assistance of Non-Invasive EECP® Therapy
Healthy Heart’s medical director, Dr. Suresh Gadasalli, says the painless treatment has reduced or eliminated angina pain, fatigue, and shortness of breath for hundreds of the center’s patients

Helping Men To Perform To Their Best Abilities
Michael S. Kaplan was presented with an award by the Nevada Family Practice Association as “Consultant of the Year” and Las Vegas Magazine as “Top Doctor”. See how he can help resolve your concerns.

Registration Open for 1st Cancer Cachexia Conference in Boston, MA on September 21-23, 2012
We are pleased to announce that registration is now open for the first Cancer Cachexia Conference entitled, “Cancer Cachexia: Molecular Mechanisms and Therapeutic Approaches” to be held in Boston, USA on September 21-23, 2012, co-hosted by The Oh

Boston Cosmetic Surgery Center Introduces ChestSculpt for Treatment of Gynecomastia
May 16, 2012 -- Marshfield, MA - (May 16, 2012)-- Edwin Ishoo, MD, a cosmetic surgeon in Marshfield and Brookline, Massachusetts area, is pleased to offer ChestSculpt, an innovative and advanced procedure for treatment of gynecomastia.

Great Wall Chinese Medicine Has Big Event of Diabetes
This is a phenomenal opportunity for the public to learn techniques for well-being and to learn the newest information on Diabetes Prevention from one of the top Diabetes Experts in the world, Dr. Wang who will only be in the United States for 10 day